Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer
Titel:
Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer
Auteur:
Buteau, James P. Moon, Daniel Fahey, Michael T. Roberts, Matthew J. Thompson, James Murphy, Declan G. Papa, Nathan Mitchell, Catherine De Abreu Lourenco, Richard Dhillon, Haryana M. Kasivisvanathan, Veeru Francis, Roslyn J. Stricker, Phillip Agrawal, Shihka O'Brien, Jonathan McVey, Aoife Sharma, Gaurav Levy, Sidney Ayati, Narjess Nguyen, Andrew Lee, Su-Faye Pattison, David A. Sivaratnam, Dinesh Frydenberg, Mark Du, Yang Titus, Jehan Lee, Sze-Ting Ischia, Joseph Jack, Greg Hofman, Michael S. Emmett, Louise